Spire Wealth Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Spire Wealth Management’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-161,776	Closed	-$40.4K	–	2300
2024 Q2	$40.4K	Buy	161,776 +152,807	+1,704%	+$56.8K	﹤0.01%	1190
2024 Q1	$6.46K	Sell	8,969 -9,986	-53%	-$7.24K	﹤0.01%	1867
2023 Q4	$13.6K	Buy	+18,955	New	+$18.3K	﹤0.01%	1651
2023 Q3	–	Sell	-1,500	Closed	-$3.78K	–	2486
2023 Q2	$3.78K	Hold	1,500	–	–	﹤0.01%	2074
2023 Q1	$3.4K	Buy	+1,500	New	+$3.8K	﹤0.01%	2131

Spire Wealth Management's VAXX Position: Q3 2024 in Review

Spire Wealth Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 161,776 shares — an estimated $40.4K sold.

Spire Wealth Management first reported a position in VAXX in Q1 2023 and held it in 5 quarters. The position peaked at $40.4K in Q2 2024. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

Spire Wealth Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
Spire Wealth Management sold 161,776 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $40.4K.
Spire Wealth Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 5 quarters.
Spire Wealth Management's Vaxxinity, Inc. Class A Common Stock position peaked at $40.4K in Q2 2024.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Spire Wealth Management's 13F filing for Q3 2024, filed 15 Oct 2024.